Adrian Woolfson
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Adrian Woolfson
The proxy statement of Sangamo Therapeutics, Inc reports total compensation of $2,310,510 for Adrian Woolfson in fiscal 2019, including a base salary of $449,732.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Sangamo Therapeutics, Inc (SGMOQ)
Proxy statement
Start not stated–2020-06-24
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Sangamo Therapeutics, Inc (SGMOQ) | Executive Vice President, Research and Development | $449,732 | $2,310,510 |
Recent activity
No call appearances or filed executive changes recorded yet.